Tofflon Science and Technology Group Co., Ltd. (SHE:300171)

Market Cap	9.27B -17.9%
Revenue (ttm)	5.20B +3.3%
Net Income	207.76M +38.9%
EPS	0.27 +35.0%
Shares Out	760.85M
PE Ratio	45.10
Forward PE	25.29
Dividend	0.11 (0.90%)
Ex-Dividend Date	Jun 1, 2026

Volume	11,308,351
Open	12.07
Previous Close	12.10
Day's Range	11.98 - 12.34
52-Week Range	10.42 - 20.37
Beta	0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHE:300171

Tofflon Science and Technology Group Co., Ltd. engages in the research, development, production, sales, and services of pharmaceutical equipment in China and internationally. The company offers technological research, including cell technology, complex preparation, injection, and OSD laboratory; instruments comprising cell therapy and nucleic acid drugs instruments, laboratory facilities, and table reactor; single use technology that include bioreactors, liquid distribution systems, sterile bags, process chromatography, membrane filtration syst...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1993
• Employees: 5,479
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300171

Financial Performance

In 2025, SHE:300171's revenue was 5.23 billion, an increase of 4.45% compared to the previous year's 5.01 billion. Earnings were 200.38 million, an increase of 3.24%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 31, 2026

Data Sources Report a data error